Christi Shaw - 27 May 2026 Form 4 Insider Report for Kyverna Therapeutics, Inc. (KYTX)

Reporting relationship: Executive Chairperson, Director
Issuer ticker: KYTX
Reported as of: 27 May 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 29 May 2026, 16:30:04 UTC
Prior SEC filing: 14 Jan 2026
Next SEC filing: 05 Jun 2026
Source filing: View source filing
Reporting owner signature: By: /s/ Samantha H. Eldredge, as Attorney-in-fact

Key filing fact

Christi Shaw filed Form 4 for Kyverna Therapeutics, Inc. (KYTX) on 29 May 2026.

Key facts

This page summarizes Christi Shaw's Form 4 filing for Kyverna Therapeutics, Inc. (KYTX).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 29 May 2026, 16:30.

Change

Previous filing in this sequence was filed on 14 Jan 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001702473 Primary reporting owner

Shaw Christi

Relationship: Executive Chairperson, Director
Address: C/O KYVERNA THERAPEUTICS, INC., 5980 HORTON ST., STE 200, EMERYVILLE
Signature: By: /s/ Samantha H. Eldredge, as Attorney-in-fact
Signature date: 29 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

KYTX transaction

Common Stock

Tax liability

Transaction value
Shares: -4,194
Change %: -5.9%
Price: $8.59^*
Shares after: 66,741
Date: 27 May 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents the number of shares withheld by and surrendered to the Issuer on May 27, 2026, to satisfy tax withholding obligations that arose in connection with the vesting of a restricted stock unit award for 16,634 shares that vested in full on May 27, 2026.